Great Point Partners LLC Ascendis Pharma A/S Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$91.45 - $139.12 $27.4 Million - $41.7 Million
-300,000 Closed
0 $0
Q3 2019

Nov 15, 2019
SELL
$95.8 - $118.9 $19.2 Million - $23.8 Million
-200,000 Reduced 40.0%
300,000 $28.9 Million
Q2 2019

Aug 14, 2019
BUY
$107.11 - $132.09 $9.1 Million - $11.2 Million
85,000 Added 20.48%
500,000 $0
Q1 2019

May 14, 2019
BUY
$62.15 - $129.99 $25.8 Million - $53.9 Million
415,000 New
415,000 $48.8 Million

Others Institutions Holding ASND

# of Institutions
241
Shares Held
58.8M
Call Options Held
250K
Put Options Held
377K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.12B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email